Literature DB >> 3926659

Changes in plasma hormone profiles after tumor transplantation into syngeneic and allogeneic rats.

H O Besedovsky, A del Rey, M Schardt, E Sorkin, S Normann, J Baumann, J Girard.   

Abstract

Transplantation of 2 chemically (DMBA, MCA)-induced tumors into syngeneic female or male DA strain rats elicited hormonal changes during tumor growth. Plasma levels of 7 different hormones were studied. Tumor cells in syngeneic recipients produced a biphasic decrease in insulin, an early increase in prolactin, and a late-phase decrease in thyroxine. Corticosterone decreased in female tumor bearers but increased in males. This difference may reflect differences in the tumors transplanted. Male rats had a decrease in testosterone during the late phase of tumor growth, while females had a biphasic decrease in progesterone and a late-phase increase in growth hormone. The tumors used were moderately immunogenic in syngeneic recipients. However, tumor transplantation to allogeneic recipients produced an early decrease in growth hormone and no change in insulin, corticosterone or thyroxine. Further, transplantation of normal liver cells to syngeneic or allogeneic recipients produced no hormonal abnormalities. This study demonstrates that hormonal changes which are not observed with normal cells or allogeneic tumor transplantation can occur within 2 days of syngeneic tumor transplantation. Progressive tumor growth is characterized by a worsening endocrine imbalance which involves multiple hormone systems.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3926659     DOI: 10.1002/ijc.2910360213

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

Review 1.  The immune system as a regulator of thyroid hormone activity.

Authors:  John R Klein
Journal:  Exp Biol Med (Maywood)       Date:  2006-03

Review 2.  Fifteenth Gaddum Memorial Lecture December 1994. Stress and the neuroendocrine-immune axis: the pivotal role of glucocorticoids and lipocortin 1.

Authors:  J C Buckingham
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

3.  Estrual cycle periodicity in hormone-independent tumor-bearing mice.

Authors:  L G Vauthay; Y P de Bonaparte
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

Review 4.  Macrophage infiltration and tumor progression.

Authors:  S J Normann
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

5.  Free thyroxine level as an independent predictor of infection-related mortality in patients on peritoneal dialysis: a prospective multicenter cohort study.

Authors:  Hee-Yeon Jung; Jang-Hee Cho; Hye Min Jang; Yon Su Kim; Shin-Wook Kang; Chul Woo Yang; Nam-Ho Kim; Ji-Young Choi; Sun-Hee Park; Chan-Duck Kim; Yong-Lim Kim
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

6.  Cancer as a tool for preclinical psychoneuroimmunology.

Authors:  Jeremy C Borniger
Journal:  Brain Behav Immun Health       Date:  2021-09-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.